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Abstract 
Background and aims: Protein Kinases having significant effects on signal transduction as well as 
most of the cellular processes, frequently causes diseases. A large number of disease-causing 
mutations have been recognized from several protein kinases. Therefore, KinMutBase database, a 
comprehensive database for diseases causing mutations in Protein Kinase domain was established 
previously, where all the mutation related information was positioned. Protein kinases are related 
with numerous life threatening diseases including cancers. Hence to analyze pathogenic mutations 
in kinase domain level to figure out the characterization of mutation pattern was the crucial concern 
of this thesis work. 
Methods: KinMutBase were thoroughly updated with new mutations as well as new gene entries 
where mutations are happening in their kinase domain range. Gene and respective protein sequences 
reported in the dataset were downloaded to perform Multiple Sequence Alignment. Conserving all 
those sequence to rearrange the mutation positions, BioEdit, software for assembling conserved 
sequence was used. By this mean, every mutation had given to new positions in the sequence file. In 
conclusion, statistical analyses were performed with R to examine mutation pattern. In addition, 
mutation pattern and mutation rate of Protein Serine/ Threonine kinase group as well as Protein 
Tyrosine kinase group in comparison with background data set (Faisal I., 2012) was also calculated 
for individual amino acids and for different amino acid groups. 
Results: From this study it can be proposed that several genes like as ACVRL1, STK11, and BTK 
could be easily mutated in any amino acid positions between their kinase ranges. Yet again, in 
kinase range some amino acid like Arginine (R) can be easily and frequently mutated. Leucine (L) 
has also a good chance for mutation readily. Certain position in MSA files which also have chance 
where mutations can happen quiet frequently has been figure out.  
Conclusion: Throughout the kinase region, several proteins, some certain amino acids as well as 
some specific positions are identified for causing mutations in genomic level. Specially, Non polar 
aliphatic amino acid group has the higher tendency for causing mutations which easily leads to 
diseases.  
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1. INTRODUCTION 
Protein kinase one of the largest superfamily of eukaryotes regulates most of the cellular processes 
of eukaryotic cells including proliferation, gene expression, metabolism, motility, membrane 
transport and apoptosis by a major mechanism referred as phosphorylation. Being involvement of 
almost every activity of cells, key regulators of biological control and signaling cascades, protein 
kinases are more susceptible for dieses causing mutations (Hanks et al., 2003). 
Variation of nucleotide inside a gene is the change of any nucleotide (A, T, C, or G) in DNA 
sequence of any species. Variations appear for different factors and replication errors during DNA 
replication stage of meiosis cell division. Variation could be harmful, neutral and as well as 
sometimes it could be beneficial. When the variation is harmful and leads to diseases, then it could 
be mentioned as Pathogenic mutations (Petrov et al., 2005; Sawyer et al., 2007). Therefore, 
Pathogenic Mutations or Disease-causing mutations may be referred as an error or fault in the gene 
that causes damage of the production of a protein and hence create certain clinical symptoms (Gang 
et al., 2010). 
According to the cancer genome project, human genome encodes some 518 catalytically active 
protein kinases among them 180 protein kinases are responsible for diseases causing mutations and 
hence produce life threatening diseases. Thereafter it was required to generate and preserved a 
comprehensive database enthusiastic for protein kinase related mutations data, diseases, patient 
name, sequences, structures and so on. For this point of view, KinMutBase were established and 
maintained by IBT, University of Tampere (Ortutay et al., 2005). 
Since defects in kinases frequently cause diseases, mutation data is valuable for researchers from 
several fields. Most of the diseases that are associated with protein kinases are numerous cancers. 
Therefore, inhibiting the protein kinases, which means inhibiting of phosphorylation, can treat these 
diseases (Cohen P.et al., 2002). Hence, protein kinase inhibitors could also be used as drugs. From 
those above discussion it is quite clear that the KinMutBase database is fundamental for 
understanding the characterization of pathogenic mutations. KinMutBase datasets describe 
mutations on the genomic, RNA, and protein level, and contain information about mutations such as 
the number of patients, number of unrelated families, and the number of patients homozygous for a 
mutation and so on. KinMutBase was updated whenever it needed to keep the dataset frequent and 
rationalized. 
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In conclusion, the aim of this thesis work was to update the databases, add new mutations as well as 
related diseases, patients and families. It was also concern to find new genes where mutations are 
happening in kinase region. Establishing a pattern how mutation are happening in genome level and 
to figure out which amino acids are frequently causes diseases causing mutations, which gene are 
most vulnerable for mutations was also a prime concern.  
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2. THEORETICAL BACKGROUNDS 
2.1 Protein Kinases 
Protein Kinases are enzymes that modify localization and overall function of many proteins by 
attaching phosphate groups to them at specific sites by a process called Phosphorylation. Protein 
Kinases are key elements in intracellular signaling pathways that control many physiological 
processes. It constitute one of the largest 'super families’ of eukaryotic proteins (approximately 2% 
of the human genes) and hence play many significant roles in biology and disease (Hanks et al., 
2003). Protein kinases organize the activity of almost all cellular processes including proliferation, 
gene expression, metabolism, motility, membrane transport, apoptosis and particularly prominent in 
intracellular signaling transduction (Calvez et al., 2002). Recent analyses suggest that the human 
genome encodes some 518 catalytically active protein kinases among them 478 belong to a single 
superfamily whose catalytic domains are related in sequence (Bignell et al., 2006). 
2.1.1 Classification of Protein Kinases 
According to Hanks, the eukaryotic protein kinases make up a large superfamily of homologous 
proteins which are related by virtue of their kinase domain or catalytic domain consist of 
approximately 250-300 amino acid residues and contain 12 conserved sub domains that fold into a 
common catalytic core structure, as revealed by the 3-dimensional structures of several protein-
Serine kinases (Hanks et al., 1995). Therefore, Protein kinases fall into three broad classes 
characterized by kinase domain phylogeny with respect to related substrate specificities and modes 
of regulation (Hanks et al., 1988). 
There are two main subdivisions within the superfamily: the protein-Serine/Threonine  kinases and 
the protein-Tyrosine kinases (The eukaryotic protein kinase super family: kinase (catalytic) domain 
structure and classification (Hanks et al., 1995)). 
Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins which 
share a conserved catalytic core common with both Serine/Threonine and Tyrosine protein kinases. 
There are a number of conserved regions in the catalytic domain of protein kinases. In the N-
terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity 
of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the 
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catalytic domain there is a conserved aspartic acid residue, which is important for the catalytic 
activity of the enzyme (Knighton et al., 1991). Hence the classification appears like as follows:  
 Serine/Threonine -protein kinases 
 Tyrosine-protein kinases 
 Dual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target 
proteins). Histidine and Arginine kinases also exist in the protein kinase family. 
 
2.1.2 Functions of Protein Kinases 
Protein phosphorylation is one of the most important signal transduction mechanisms by which 
intercellular signals control central intracellular processes such as ion transport, cellular 
proliferation, and hormone responses. Therefore protein kinases can serve following physiological 
functions- 
 Cell cycle regulation 
 Signal Transduction 
 Angiogenesis 
 Immune Circumvention/ Evasion 
 Proliferation 
 Apoptosis 
 Growth regulation 
 Tissue remodeling  
(Steinberg et al., 2004; Diaz –Moralli et al., 2012:Kim S et al., 2002) 
 
2.1.3 Serine/Threonine protein kinases 
A Serine/Threonine  protein kinase (EC 2.7.11.1) also referred as Serine kinase or Threonine kinase 
is a kinase enzyme that phosphorylates the OH group of Serine or Threonine which have similar 
side chains. Protein Serine/Threonine  kinases (PSKs) play a principal role in cellular homeostasis 
and signaling through their ability to phosphorylate transcription factors, cell cycle regulators, and a 
vast array of cytoplasmic and nuclear effectors (Krebs et al., 1987). Therefore, Serine/Threonine 
kinase receptors play a role in the regulation of cell proliferation, programmed cell death 
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(apoptosis), cell differentiation, and embryonic development. PSK have been associated in 
numerous human cancers. 
 
2.1.4 Tyrosine Protein Kinases 
A Tyrosine kinase (EC 2.7.10.2) is an enzyme that can transfer a phosphate group from ATP to 
a protein in a cell. It has the purposes of operating an "on" or "off" switch in many cellular 
functions. Protein-Tyrosine kinases (PTKs) are important regulators of intracellular signal-
transduction pathways facilitating development and multi-cellular communication in Eukaryotes 
(Hunter et al., 2001). Their activity is normally tightly controlled and regulated. Tyrosine kinases 
activate numerous signaling pathways, leading to cell proliferation, differentiation, migration, and 
metabolic changes (Schlessinger et al., 1992). Moreover, enhanced Tyrosine kinase activity is the 
assurance of a significant element of cancers as well as other proliferative diseases. 
 
2.1.5 Mutations in diseases 
Being key regulators of most cellular pathways, in the meantime protein kinases are frequently 
associated with diseases, either as causative agents or as therapeutic intervention points. The Protein 
kinase family’s significant function in signal transduction for all organisms makes it a very 
attractive target class for therapeutic interventions in many disease states such as cancer, diabetes, 
inflammation, and arthritis (Calvez et al., 2004). Furthermore, it has been established that the 
activity of protein kinases are altered in several human diseases such as cancer and autoimmune 
disorders. Kinase-diseases associations have summarized 180 kinases which are linked with 
numerous diseases. According to Kinase-diseases associations over 180 of the 518 human kinases 
are known to be mutated or imperfectly controlled in various diseases. 
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2.2 Hanks Subdomains 
The eukaryotic protein kinases are related by virtue of their kinase domains also known as catalytic 
domains, that consists of around 250-300 amino acid residues. These kinase groups contain 12 
kinase sub domains which can fold into a common catalytic core structure (Hanks et al., 1995). 
2.2.1 The Homologous Kinase Domains 
The kinase domains of eukaryotic protein kinases connect according to their catalytic activity. The 
kinase domains are further subdivided into 12 smaller sub domains indicated by Roman numerals. 
According to Hanks these twelve regions recognized being invariant or nearly invariant throughout 
the eukaryotic domain of life. 
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Table 2.1: Hanks Protein kinase Sub domain region 
 
During this thesis work Hanks twelve sub domains have been used to identify kinase specific 
motifs. 
  
SL No Subdomain Name Subdomain  Region Name of Amino acids within this 
subdomain range
2 Hanks_II 424-436 Q,Y,D,V,A,I,K,M,E,G, and S
3 Hanks_III 437-450 M,S,E,D,F,I,A,K,V, and N
4 Hanks_IV 452-466 L,S,H,E,K,V,Q,Y,G,C, and T
5 Hanks_V 467-491 Q,R,P,I,F,T,E,Y,M,A,N,G,C,L, 
and H
6 Hanks_V1A 492-514 R,F,Q,T,L,E,M,C,K,D,V,A,Y, 
and S
7 Hanks_VIB_cat 515-532 K,Q,F,L,H,R,D,A,N,C, and V
8 Hanks_VII 533-548 G,V,K,S,D,F,L,R, and Y
9 Hanks_VIII_A_ 549-568 D,E,Y,T,S,V,G,K,F,P,R, and W
10 Hanks_IX 569-599 L,M,Y,S,K,F,D,I,W,A,G,V,E, 
and P
11 Hanks_X 600-620 R,F,T,N,S,E,A,H,I,Q,G,L,Y, 
and P
12 Hanks_X1 621-646 L,A,S,E,K,V,Y,T,I,M,C,W,H,D,
R,P, and F
1 Hanks_I 397-423 I,N,P,K,D,L,T,F,E,G,Q,V,Y,W, 
and R
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2.3 Amino acids 
Amino acids are physiological macromolecules and building blocks of all biological proteins having 
a common structure. Amino acids, as the name implies, have two functional groups, an amino group 
(–NH2) and a carboxyl group (–COOH) and a side chain that is exclusive for each amino acid. 
Amino acids link together via peptide bonds in a particular order as defined by genes. C (carbon), H 
(hydrogen), O (oxygen), and N (nitrogen) are vital elements of an amino acid. Amino acids play 
central roles both as building blocks of proteins and as intermediates in metabolism. The 20 amino 
acids that are found within proteins convey a vast array of chemical versatility. While amino acids 
are fundamental macromolecules of protein formation, they also play vital role in many 
physiological activities. Humans can produce 10 of the 20 amino acids which are referred as non-
essential amino acids. However, other amino acids which are referred as essential amino acids are 
not synthesized automatically by cells and hence must be supplied by means of nutrition, protein 
containing foods, protein diets and so on (Champe et al., 2004; Nelson et al., 2005; Kyte et al., 
1982;  Ambrogelly et al., 2007;  Meierhenrich et al., 2008;  Erives et al., 2011). 
 
2.3.1 Classification of amino acids 
Functional and structural properties of amino acids vary a lot depending on the side chains. 
Depending upon their polarity, acidic, basic or neutral property, aromatic property or aliphatic 
property amino acids are classified differently. Classification of amino acids depending on their 
properties are given below-  
 A, C, G, I, L, M, F, P, W, and V are in the group of non-polar amino acids. 
 R, N, D, E, Q, H, K, S, T, and Y amino acids indicate polar properties. 
 R, H and K are positively charged (basic) amino acids. 
 D and E are acidic amino acids comprising negative charge. 
 A, N, C, Q, G, I, L, M, F, P, S, T, W, Y, and V are neutral (uncharged) amino acids. 
 F, W (Non polar), and Y (Polar) having aromatic ring in their structure. 
 G, A, V, L, and I are aliphatic non-polar amino acid. 
 
Therefore, amino acids vary a lot in properties. Some of them show mixed properties and therefore 
might be considered member of more than one group (Koolman et al., 1994; Champe et al., 2004; 
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Nelson et al., 2005; Kyte et al., 1982; Ambrogelly et al., 2007; Meierhenrich et al., 2008; Erives et 
al., 2011). 
Amino acids were divided in five groups during this thesis work in order to compare variability and 
mutability of different groups. These five groups were acidic (polar negatively charged), basic 
(polar positively charged), neutral (no charge), aliphatic (non-polar) and amino acids containing 
aromatic ring. Phenylalanine (F), Tyrosine (Y) and tryptophan (W) are the amino acids which 
contain aromatic ring in their structure therefore comprises aromatic group. Only aspartic acid (D) 
and glutamic acid (E) are acidic in nature.  
 
2.4 Pathogenic Mutations 
Mutations are alterations in the genetic sequence, and they are a main cause of diversity among 
entities. These variations occur at many different levels, and they can have widely differing 
consequences. Although various types of molecular changes exist, the word "mutation" typically 
refers to a change that affects the nucleic acids (Loewe, 2008). Therefore, pathogenic mutation or 
variation is the change of nucleotide (A, T, C, or G) in DNA sequence of any species. Pathogenic 
Mutations or Disease-causing mutations may be referred as an error or fault in the gene that causes 
damage of the production of a protein and hence certain clinical symptoms can occur. If mutations 
occur in non-germline cells, then these changes can be categorized as somatic mutations. From an 
evolutionary perspective, somatic mutations are uninteresting, unless they occur systematically and 
change some fundamental property of an individual--such as the capacity for survival. For 
example, cancer is a potent somatic mutation that will affect a single organism's survival (Loewe, 
2008). Disease-causing mutations occur often inside the protein (buried) and at hydrogen-bonding 
residues (Gong et al., 2010). According to Wang and Moult, several characteristics such as high 
conservation between species, presence in several haplotypes, heteroplasmic state and good 
correlation between heteroplasmic level and clinical symptoms are notable criteria for a pathogenic 
mutation (Wang et al., 2001). Certain additional tools have also been suggested to understand 
pathogenic mutations, including the effects of single nucleotide polymorphisms in the coding region 
on protein function, protein stability, ligand binding, catalysis, allosteric regulation and post-
translational modification (Wang et al., 2001). 
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The smallest mutations are point mutations, in which only a single base pair is changed into 
another base pair. Another kind of mutations called nonsynonymous mutation, in which an amino 
acid sequence is changed. Such mutations lead to either the production of a different protein or the 
premature termination of a protein. As opposed to nonsynonymous mutations, synonymous 
mutations do not change an amino acid sequence, although they occur, by definition, only in 
sequences that code for amino acids. Synonymous mutations exist because many amino acids are 
encoded by multiple codons. Base pairs can also have diverse regulating properties if they are 
located in introns, intergenic regions, or even within the coding sequence of genes. 
Mutations may also take the form of insertions or deletions, which are together known as indels. 
Indels can have a wide variety of lengths. At the short end of the spectrum, indels of one or 
two base pairs within coding sequences have the greatest effect, because they will inevitably cause a 
frameshift (only the addition of one or more three-base-pair codons will keep 
a protein approximately intact). At the intermediate level, indels can affect parts of a gene or whole 
groups of genes. 
In conclusion, Mutational effects can be beneficial, harmful, or neutral, depending on their context 
or location. Most non-neutral mutations are deleterious. In general, the more base pairs that are 
affected by a mutation, the larger the effect of the mutation, and the larger 
the mutation's probability of being deleterious. 
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3. OBJECTIVES 
 
Since defects in kinases frequently cause diseases .The key objectives of this thesis work were – 
 Established the context that kinase domain is more likely to be mutated and Causing 
different diseases including various types of cancers. 
 Characterization of pathogenic mutations in kinase domain. 
 To figure out new mutations and new genes which cause mutations in kinase domain. 
 Remapping of mutation positions to find out which position is more likely to be mutated. 
 To establish the fact that certain genes (like as STK11, BTK, and ACVRL1) have shown the 
tendency to be mutated easily. 
 Statistical analysis to understand which amino acid is most frequent for diseases causing 
within kinase range. 
 Discovering abundances and relative mutability of individual amino acids and amino acid 
groups for pathogenicity in comparison with PSK domain group, PTK domain group and 
Background dataset. 
 Discover the protein structure features in terms of mutations in that respective protein. 
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4. MATERIALS AND METHODS 
 
4.1 Materials 
4.1.1 KinMutBase mutation dataset 
There were previously available KinMutBase (http://bioinf.uta.fi/KinMutBase/), a database for 
diseases causing mutations in kinase domain created and maintained by Institute of Biomedical 
Technology (IBT) of University of Tampere. This dataset describe mutations on the genomic, RNA, 
and protein level, and contains information on existence of mutations such as the number of 
patients, number of unrelated families, and the number of patients homozygous for a mutation 
(Ortutay et al., 2005). 
Previously available KinMutBase mutation dataset contains 41 genes among them, RPS6KA3 and 
JAK3 has two different kinase domain ranges. 17 genes are in Serine/Threonine protein kinase as 
well as 24 genes are in Tyrosine protein kinase. 
The Previous version of KinMutBase (Ortutay et al., 2005) contains 709 mutations among them 
232 entries for Serine and 477 entries for Tyrosine. 
 
4.1.2 Updated version of KinMutBase mutation dataset 
During this thesis work, The KinMutBase dataset was systematically updated. The new dataset 
currently comprises 19 more new genes. Among them 17 are in Serine/Threonine protein kinase 
and rest of two in Tyrosine Kinase. The newer version of KinMutBase currently contains 710 new 
mutations among them 540 entries for Serine and 170 entries for Tyrosine. 
However, 1419 pathogenic mutations from 60 reported protein or gene sequences which have 
mutations in their kinase domain both in Serine/Threonine kinase and Tyrosine kinase were selected 
for further analysis in this thesis work. 
4.1.3 Background dataset 
The neutralized data for 20 amino acids derived from 5,958 pathogenic mutations of VariBench 
(http://bioinf.uta.fi/VariBench/), a benchmark database for human protein variations created and 
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maintained by Institute of Biomedical Technology (IBT) of University of Tampere was used as 
background dataset during this thesis work (Nair et al., 2012) which was used as Imrul’s master’s 
thesis also (Faisul I, 2012). 
 
4.1.4 Sequences 
According to the kinase domain range, selected proteins sequences for all reported 
Serine/Threonine kinase and their corresponding gene sequences as well as Tyrosine kinase and 
their gene sequences were downloaded from Ensembl database in FASTA format. Multiple 
sequence alignments (MSA) were made for Serine/Threonine kinase file and Tyrosine kinase file 
separately.  
 
4.1.5 BioEdit- Tool for assembling conserved sequences 
BioEdit, a biological sequence alignment editor was used (Hall et al., 1997) to access the MSA files 
both of the groups and make the sequences more preserved to each other. Hence, rearranging the 
mutation positions were done by virtue of BioEdit.   
 
4.1.6 Software for statistical analysis 
R (http://www.r-project.org/) was selected here for both data management and statistical analysis. 
Various plots have also been generated by using R during this thesis work. 
 
4.1.7 Software for programming 
Programming was also a significant concern during this thesis work. Programming was required to 
cut all protein sequences according to their kinase range, find the proportion of amino acid in the 
sequences and it was also very helpful for file management and other computational management 
like as data manipulation. Python (www.python.org) programming software or programming 
language was used here for programming issues especially for picking up kinase region as well as 
data manipulation. 
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4.1.8 Software for Protein Visualization 
UCSF CHIMERA (http://www.cgl.ucsf.edu/chimera/), an extensible molecular modeling system 
was used for molecular visualization of mutations in kinase domain of a selected Protein. Mutations 
were also labeled by using CHIMERA during this thesis work. 
4.2 Methods 
4.2.1 Preparation of datasets 
 
4.2.1.1 Apprising the database 
By the help of MUTbase software, KinMutBase was thoroughly updated at the beginning of this 
thesis work. MUTbase software (Riikonen et al., 1999), which was formerly established to 
construct and maintain locus-specific mutation databases, was also modified to conserve data 
concurrently for several kinases and to accept mutations only in the kinase domain in KinMutBase 
dataset. During the updating procedure of the dataset a previously available Perl-cgi submission 
form has been used which is capable of inserting new mutation data in the database which is 
publicly accessible on the Internet. The data were handled by Perl scripts; therefore they are capable 
of interpreting the most common mutation types such as point mutations, insertions and deletions. 
Other cases are implicated manually. 
As a result of the work performed in this thesis the most recently available KinMutBase contains 
these newly identified mutations (Mainly missense mutation, some nonsense mutation and very few 
expressive polymorphism has also been included) that occurred in Kinase domain. 19 new genes 
and the analogous 208 new mutations of these genes have been supplementary in the dataset. 
However, altogether 60 new proteins, their corresponding genes and 1419 pathogenic mutations 
have been selected for the further analysis. 
 
4.2.1.2 Downloading Protein Sequences 
Two groups were designed conferring to Serine/Threonine Kinase and Tyrosine kinase. Separate 
alignments are presented for Serine/Threonine kinases (PSKs) and Tyrosine kinases (PTKs), 
together with mutations. Serine/Threonine kinase contains 34 genes including RPS6KA3 has two 
kinase domain ranges. On contrary, Tyrosine contains 26 genes consuming JAK3 has two different 
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kinase ranges. The protein sequences of these two diverse groups were collected in FASTA format 
and stored for making multiple sequence alignments. Multiple sequence alignments (MSA) were 
made for each file containing the sequences of all genes of those groups together. These sequence 
alignments were further required for conserving as well as mapping for the reposition of all these 
mutations. 
 
4.2.1.3 Conservation of the sequences 
To generate conservation of the Serine/Threonine sequence file and Tyrosine sequence file, BioEdit 
(Hall et al., 1997), a biological sequence alignment editor which basically practiced ClustalW 
alignment sequence was used during this thesis work. BioEdit can easily access MSA data files. It 
has the feature “Automated ClustalW alignment” and “Edit” options for making it more preserved. 
Therefore, it was very handy to keep a record how many characters have been cut off to make all 
those sequences conserved to each other. Using BioEdit, it was possible to specify the total number 
of the characters that was removed to make the sequences more conserved. From the BioEdit 
software two different files both for Serine/Threonine and Tyrosine were kept for further mutation 
mapping. 
The alignments were further visualized with MultiDisp (http://bioinf.uta.fi/cgi-bin/MultiDisp.cgi ) 
(P. Riikonen and M. Vihinen). In below Figure-4.1 shows how it looked like in MultiDisp for 
Serine/Threonine kinase file. 
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Figure 4.1 Alignments of Serine/Threonine protein kinase produced by MultiDisp 
 
4.2.2 Mutation Mapping 
The KinMutBase original data file comprises the record of every individual mutation named after 
dissimilar accession numbers. During this thesis work, to find out if there was any correspondence 
between the pattern of how mutations occur and which position has greatest frequency for a certain  
mutation, mutation remapping was obligatory and hence completed very carefully. For doing so, 
first of all for each and every accession number of KinMutBase data file, mutation position in 
KinMutBase was noted. Thereafter, that particular accession number lies on which group 
(Serine/Threonine protein kinase or Tyrosine protein kinase) was monitored. Formerly, two 
separated MSA file for Serine/Threonine  protein kinase and Tyrosine protein kinase was viewed  
by using BioEdit software in accordance with that respected gene in that particular accession 
number.  In Table 4.2 below, the picture shows how the new position of every mutation looks like 
in the MSA files. Therefore, every mutation was documented and had a new position in MSA file. 
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During conserving the MSA file some positions were cut off which have more gaps, a very few 
mutations (only 12 among those 1419 mutations) reclined between those cut off regions. 
Table 4.2 is the sample of 15 selected mutations according to their accession number after 
repositioning them in MSA file. 
SL 
NO 
Accession 
Number 
Gene 
Name 
Kinase SwissP
rot ID 
Mutation Position 
in 
Kinase 
Range 
Original 
Amino 
Acid 
Change 
AA 
Position 
in MSA 
files 
1 K00001 TGFBR2 Serine/T
hreonine  
P37173 R537P 537 R P 357 
2 K00002    E526Q 526 E Q 341 
3 K00003    T458A 458 T A 263 
4 K00004    T315M 315 T M 88 
5 K00005    D405G 405 D G 198 
6 K00561    V250A 250 V A 8 
7 K00562    Y448C 448 Y C 253 
8 K00563    K488E 488 K E 302 
9 K00564    M373I 373 M I 155 
10 K00565    S401F 401 S F 194 
11 K00739    E480X 480 E X 290 
12 K00740    T516K 516 T K 331 
13 K00741    V513E 513 V E 328 
14 K00742    R528H 528 R H 343 
15 K00743    D524N 524 D N 339 
 
Table 4.2: Repositioning numbers of fifteen selected mutations among 1419 mutations were collected from 
MSA file. 
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4.2.3 Patterning Amino acids in Fasta file 
During remapping of the mutation positions it was also marked which amino acids were changed 
and thus occurs a kinase mutation in a different file. Accordingly, anyone interested about this 
thesis work could perceive how mutations are trendy in Kinase domain part of a protein. Also it 
could be also traceable which genes have the highest chance to be mutated easily. The Figure- 4.3 
indicates the fact that certain genes like as ACVRL1, BTK, STK11 were more frequently mutated. 
 
Figure 4.3: Labeling of mutations happening in FASTA format of kinase domain of the proteins 
 
4.2.4 Calculating the new position and normalization of the data 
BioEdit was very beneficial while designing the new position. During the thesis work every single 
mutation was repositioned and gave a new positioning number with the help of BioEdit. Whereas 
working with the mutations data file it was required to normalize the data due to eliminating 
redundant data and data dependency. Data normalization was done for every amino acid in 
comparison with their proportion in sequence file both of PSK and PTK dataset. 
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4.2.5 Workflow for overall procedure 
Therefore, the overall workflow expressions should be similar the followings-  
Overall Working Procedure:  
 
Figure 4.4: workflow of overall procedure 
 
4.2.6 Statistical analysis 
The new mutation pattern and position was analyzed statistically both for Serine/Threonine and 
Tyrosine file. For instance, distributions of the amino acids were plotted in graphs to visualize and 
compare. Several box plots were drawn to show mutation patterns. Statistical analysis was required 
also to compare PSK and PTK group with background dataset. These figures were made not only to 
compare overall distribution of two different types of kinase mutations but also to observe the 
differences between each amino acid of both types. More details of this aspect are verified in results 
and discussion parts. 
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In addition, statistical tests for distribution comparison of both two groups’ kinase mutations were 
performed in comparison with also background data set. During this thesis work , 5,958 pathogenic 
mutations mentioned in VariBench dataset which was used for calculating Ka/Ks ratio was used as 
background dataset to compare and contrast correlation of mutation pattern (Faisal I., 2012). 
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5. RESULTS 
5.1 New data entries 
5.1.1 New Mutations both for PTK kinase and PSK kinase 
The previous version of KinMutBase contained overall 709 different mutations in 25 PTK domains 
and in 17 PSK domains including RPS6KA3 and JAK3 has two different kinase domain ranges. 
Among them, 232 mutations were presented in PSK domains and 477 mutations were in PTK 
domains. During this thesis work the database was updated systematically. The updated version of 
KinMutBase currently contains 540 newly available mutations in PSK kinase domains and 170 new 
mutations in PTK domains which are showed in Figure-5.1. However, all-together 1419 pathogenic 
mutations both in PSK kinase and PTK kinase domain are currently available in the KinMutBase 
dataset were selected. Surprisingly newly available data shows PSK domain has more entries than 
that of PTK domain. 
 
 
Figure 5.1: Comparison of PSK and PTK domain according to their previous entry and new entry. 
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5.1.2 New Genes both for PTK kinase and PSK kinase 
The new dataset contains 19 new Genes. Among them 17 are in Serine/Threonine protein kinase 
and the remaining two in Tyrosine kinase. Consequently all-together 60 new gene entries and their 
corresponding 208 new mutations were available in the dataset including JAK3 and RPS6KA3 has 
two kinase domains. 174 entries were listed for new PSK kinase and 34 entries were for PTK 
kinase. Among all these new 19 genes, the PSK kinase domain region of gene PINK1 has the 
highest numbers of mutations (60). On the contrary in the PTK kinase domain region of gene EGFR 
has the highest numbers of mutations (33) which shows in Figure –5.2.  
 
 
Figure 5.2: Reported new mutations as well as new genes in KinMutBase. Genes as well as reported 
mutations in Tyrosine kinases shows in green color and rest of the genes and their corresponding mutations 
are in blue. The red box mark around the bar shows the highest frequency of mutation in both PSK group and 
PTK group. 
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5.1.3 Distribution of Mutation in PSK kinase and PTK kinase 
Distribution of KinMutBase mutations according to multiple sequence alignment after remapping 
the position performed by BioEdit software in Serine/Threonine kinases (Figure-5.3) and Tyrosine 
kinase (Figure-5.4) are shown in following images. The number of missense mutations is displayed 
in the bar charts for both of those two records. 
While performing the repositioning of all those mutations in MSA file, it was noticed that position 
343 in MSA file has the highest frequencies for PSK kinase. Total 14 mutations accommodate in 
position 343. In addition, 11 mutations were countable for position 353 in PSK domain. 
 
 
Figure5.3: Distribution of KinMutBase Mutations according to MSA in Serine/Threonine kinases. Locations 
of kinase-specific motifs and sub domains are presented as red bars. 
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For PTK kinase domain position 163 and 185 in MSA file has the highest frequencies. Overall 13 
mutations had been held for position 163 and 185. Furthermore, 11 mutations are observed for 
position 186,189 and 198. Likewise, 12 mutations are noticed for position 158. 
 
 
Figure5.4: Distribution of KinMutBase Mutations according to MSA in Tyrosine kinases. Locations of 
kinase-specific motifs and sub domains are presented as red bars. 
The distribution of mutations within the domains is visualized. A large proportion of the mutations 
affect the conserved kinase motifs of Hanks (Hanks et al., 2003). Many of the mutations are in sub 
domains VIB and VIII, which are responsible for substrate recognition (Johnson et al., 1998; Taylor 
et al., 1995).  
It was also difficult to determine which amino acid has the greatest tendency to be mutated. From 
the 1419 overall mutations it appeared that Serine kinase is more likely to be mutated than Tyrosine 
kinase. Of the 17 recently added new genes and 537 newly available mutations in PSK kinase 
domains also provided support of this idea. In below Figure-5.5 demonstrates this concept.  
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Figure5.5: Comparison of original Amino acid changes for both Serine and Tyrosine kinases 
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5.2 Mutability Comparison 
5.2.1 Normalization of data 
In the mutation data file, arginine (R) had the highest frequency of triggering mutation for both PSK 
domain and PTK domain. Hence, amino acid frequencies were normalized to minimize redundancy 
and dependency in relationship with sequence data file. Figure-5.6 shows data for PSK domain, R 
has the highest rate even though R was not that frequently in sequence data file for Serine. Leucine 
(L) has peak proportion in overall sequence file for Serine. 
 
 
Figure 5.6: Comparison of Percentage of Serine in sequence data files in accordance with mutation data file 
Similarly, in Figure-5.7 for PTK domain, R has the highest rate even though R was not frequently 
in sequence data file for Serine. Leucine shows a peak proportion in overall sequence file for 
Tyrosine also. 
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Figure 5.7: Comparison of Percentage of Tyrosine in sequence data files in accordance with mutation data 
file 
 
5.2.2 Comparison of PSK and PTK normalized dataset 
Normalization of both the PSK and PTK datasets was done during this thesis work. Figure-5.8 
indicates how it looks like after normalizing both PSK and PTK datasets. It can be perceived that 
after normalizing both datasets frequencies of tryptophan are greater than that of other amino acids.  
Arginine also follows the same trend for both cases. Cysteine also shows the increasing affinity. On 
the contrary alanine (A) and phenylalanine (F) shows opposite trend.  
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Figure 5.8:  Normalized data for Serine/Threonine kinase and Tyrosine kinases which shows mutation 
patterns. 
 
5.2.3 Evaluation of PSK domain and background dataset: 
Mutability or Pathogenicity of individual amino acids was calculated in order to examine their 
mutation rate. Some amino acids have revealed a higher trend of conversion to pathogenic 
mutations while others displayed lower tendency to be mutated. 
Thus, the evolution of the PSK domain and background dataset shown in Figure-5.9 where amino 
acids associated with mutation percentage is shown. In comparison with the background dataset G, 
L and R. have scored highest in pathogenic property whereas W, N, M etc. have shown the lowest 
mutation percentage. P, S, V, D etc. can be considered as almost medium in this contest. 
It sharpens the contrast when you take into consideration that even though R has lowest frequency 
in percentage data file, R has the highest value for both PSK and background dataset. Glycine also 
0
0.5
1
1.5
2
2.5
3
3.5
A C D E F G H I K L M N P Q R S T V W Y
P
er
ce
n
ta
g
e
Name of 20 amino acids
Serine Normalization
Tyrosine Normalization
 
 
 
29 
 
follows the same pattern whereas leucine has more or less similar frequency in its percentage data 
file as well as mutation data both for PSK and background dataset. 
 
 
Figure 5.9: Percentage of amino acids in both mutation data and sequence data in Serine kinase comparison 
with background pathogenic dataset 
 
5.2.4 Evaluation of PTK domain and background dataset: 
Thereafter, the evolution of PTK domain and background dataset is shown in Figure 5.10 where 
amino acids associated with mutation percentage are revealed. In comparison with background 
dataset G, L and R have scored highest in pathogenic property even though R has smaller frequency 
in data file. Again W, N, M, H etc. have shown lowest mutation percentage whereas P, S, V, D etc. 
occupy a middle ground. Hence both PSK and PTK dataset the mutation frequency followed 
analogous pattern for every amino acid. 
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Additionally even though R has lowest frequency in percentage data file, R and Y has the highest 
value for both dataset. Glycine also follows the same pattern whereas L has more or less similar 
frequency in their percentage data file as well as mutation data both for PTK and background 
dataset. It is also noticeable that G has higher frequencies in background dataset than that of PSK 
and PTK. 
 
 
Figure 5.10: Percentage of amino acids in both mutation data and sequence data in Tyrosine kinase 
comparison with background pathogenic dataset 
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After comparison of normalized data for Serine, Tyrosine and background dataset, it was noticeable 
that in all these three cases R has the highest frequency of mutation. Again tryptophan (W) also 
follows the same trend for Serine and Tyrosine but in background dataset it shows moderate level of 
mutation. Cysteine (C), tyrosine (Y) and glycine (G) have also higher tendency to be mutated.  On 
contrary, some amino acids like F, I and A trend in the opposite direction which shows in Figure-
5.11.  
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Figure 5.11: Comparison of normalized data for Serine, Tyrosine and background dataset 
 
5.2.6 Group wise evaluation of amino acid mutability between PTK, PSK and 
background data set 
Upon reviewing individual amino acid mutations, it was also a major concern in this work to 
observe group wise comparison of amino acid mutability rate in comparison with background 
dataset. The central purpose of this evaluation was to see mutability characteristic for different 
groups of amino acids.  
Group wise comparisons of amino acid mutations for the respected three groups (PSK, PTK and 
background dataset) are shown in Figure-5.12 with their corresponding proportion in protein 
sequences. 
Therefore, the mutability was compared according to normalization with original sequence 
proportions for PSK, PTK and the background dataset. Group wise amino acid in comparison with 
their respective quantities into protein sequences for all three mentioned groups are shown in 
Figure-5.12. 
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Figure 5.12: Group wise comparison of amino acids for PSK, PTK and background dataset 
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5.2.7 Co-relation coefficient: 
To measure the co-relation between these three groups (PSK, PTK and background dataset) 
statistically co relation was measured and the result found it was statistically meaningful. All three 
datasets were positively correlated with each other, which indicate that their mutation pattern 
follows similar trends.   
Correlation between Background dataset mutations and Serine/ Threonine dataset was: 0.73 
As for example the result originated was:  
 
The correlation between background dataset mutations and Tyrosine dataset was: 0.71386 
Similarly the correlation between Serine/Threonine data set and Tyrosine dataset was: 0.852997 
The correlation between Serine/Threonine and Tyrosine kinase was quite good correlation. 
Therefore it could be appealed that the mutation pattern of both PSK and PTK is corresponding 
with most of the circumstances. 
 
5.3 Visualization of mutations in Protein 
The kinase domain structure of activin A receptor type II (PDB ID: 3MY0) was used to visualize 
the localization of mutations in PSKs (Figure - 5.13). For the disease-related PTKs, no structure has 
been determined. Location of frequently mutated residues in PSKs indicated in the ACVRL1 kinase 
domain structure (PDB code: 3MY0). The figure was created with UCSF CHIMERA 
(http://www.cgl.ucsf.edu/chimera/), an extensible molecular modeling system for molecular 
visualization. Mutations were labeled with red color. The sequence and structural studies as well as 
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this molecular visualization reveal that disease-causing mutations are widely distributed within the 
domain, indicating that kinase is vulnerable for alterations in many locations. 
 
 
Figure 5.13: Molecular Visualization of ACVRL1 chain-A created by CHIMERA.  Disease-causing   
mutations are widely distributed within the domain are marked as red color here. 
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6. DISCUSSION 
Protein kinases are more likely to be mutated and thus concerning some life threatening diseases 
including various cancers. Since defects in kinases frequently causes diseases, mutation data is 
valuable for researchers from several fields. KinMutBase database was developed to integrate all 
the mutations together and related information in kinase domains. 
The new version of KinMutBase currently contains 1419 new mutations. From the overall 1419 
mutations, it appeared that Serine kinase is more likely to be mutated than Tyrosine kinase. The 
recently added 17 new genes and 537 newly available mutations in PSK kinase domains also 
provide support for this conclusion. Similarly Figure-5.2 and 5.5 demonstrate this concept 
respectively.  
 
6.1 New genes and mutations feature 
Mutations frequently occur in both Serine kinase and Tyrosine kinase. 17 new genes in Serine 
kinase as well as 208 reported mutations for those 17 Serine kinase focuses the fact that Serine 
kinase is more vulnerable for mutations than that of Tyrosine kinase.  Additionally the 537 recently 
added new mutations in Serine kinase also highlighted the fact.  
After normalizing the mutation data both for PSK kinase and PTK kinase it was noticeable that 
arginine (R) had the highest frequency of mutation. In the PSK sequence file, even though L shows 
the peak proportion, in reality arginine was mutated more repeatedly. This observation is also 
precise for Tyrosine kinases.  
While performing the repositioning of all those mutations in MSA file, it was noticed that position 
343 in MSA file has the highest frequencies for PSK kinase. Total 14 mutations accommodate in 
position 343. In addition, 11 mutations were counted for position 353 in PSK domain. This should 
be an important fact which will focus more insight inside mutation characterization. 
Meanwhile, in case of PTK kinase domain, position 163 and 185 in MSA file have the highest 
frequency of mutation. Overall 13 mutations had been held for position 163 and 185. Furthermore, 
11 mutations are observed for positions 186, 189 and 198. Likewise, 12 mutations are noticed for 
position 158. 
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6.2 Amino acid mutability features 
6.2.1 Mutability of individual amino acids for Serine/Threonine kinase 
To minimize redundancy and dependency, normalization of amino acid variability in respect to their 
proportion in protein sequences was accomplished. During the comparison of individual amino acid 
mutability for PSK, specifies that some amino acids (E, G, L, W and R) are very likely to be 
mutated (Figure-5.6). These amino acids have been found to have the higher affinity to be mutated 
while their proportions in protein sequences are relatively less (except L). Arginine and leucine are 
examples of this kind of amino acids where more variations have been noticed. Glycine has also 
shown same phenomenon similar with arginine and it is also more likely to be converted into 
diseases causing mutations. On contrary, some amino acids have been observed less frequent to 
become pathogenic in PSK group even though their proportions are higher in original protein 
sequences. A, F, K and V are the examples of this category. However, some amino acids like lysine 
and glutamine are unlikely to be changed. 
 
6.2.2 Mutability of individual amino acids for Tyrosine kinase 
During the comparison of individual amino acid mutability for PTK, identifies that some amino 
acids (E, Y) are very likely to be mutated (Figure-5.7) while their proportions in protein sequences 
are relatively less. On contrary, some amino acids have been observed less frequent to become 
pathogenic in PSK group even though their proportions are higher in original protein sequences (A, 
V, S). Few amino acids L, G, E and D in PTK have similar percentages in protein sequences as well 
as to be mutated.  
 
6.2.3 Mutability comparison of normalized amino acid data for both PSK and PTK group 
From the normalized data of amino acids of both PSK and PTK group it can be observed that for 
both these two groups R and W have higher possibilities to be frequently mutated. Cysteine and 
tyrosine also follow the similar pattern. Among these twenty amino acids, A, D, S, and V have 
almost similar frequencies to be mutated for both two groups. From the available normalized data, 
Figure-5.8 perceived that except M, Y and K rest of the amino acids in PSK group has the higher 
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tendency to be mutated than that of PTK group. On contrary, M, Y and K are more frequent in PTK 
group than that of PSK group. 
 
6.2.4 Mutability comparison of amino acid data for PSK group and background dataset 
In comparison with individual amino acid with both PSK and background dataset, Figure-5.9 
demonstrates that twenty amino acids have almost the same trends of mutability for both of these 
two groups. Therefore it can be claimed that arginine (R) has the highest frequency to be easily 
mutated for both background dataset as well as PSK dataset group. However, G and L also follow 
the similar pattern.  In PSK dataset some amino acids like W, K and F has more probability to be a 
variant mutation than that of background dataset. 
 
6.2.5 Mutability comparison of amino acid data for PTK group and background dataset 
While taking consideration of PTK and background dataset, it was correspondingly evident that R is 
more likely to be a disease causing mutations which was shown in Figure-5.10. But here in this 
case, G has the more frequency in background dataset than that of PTK. Other amino acids except 
Y in PTK follow more or less the similar pattern. Y in PTK dataset has the more frequency to be 
mutated than that of background dataset. 
 
6.2.6 Mutability of individual normalized amino acids of PSK and PTK group in 
comparison with background dataset 
Variability of amino acid groups have been more clearly observed upon normalization with their 
respective proportions in protein sequences in Figure-5.11. Few amino acids like R, C and W have 
scored highest frequencies whereas S, T, V have shown almost same lower frequency to be 
mutated. Again Y and G can be considered as almost medium in this contest. Therefore all those 
Figures-5.11 illustrates that there is a very strong correlation between the mutation patterns for 
individual amino acids between these three groups. Background dataset and PSK are positively 
correlated and the correlation between background dataset and PSK dataset is 0.73 which indicates 
quite a good correlation between these two dataset. Similarly, the positive correlation between 
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background dataset and Tyrosine is 0.71386 which also refers to a good association between these 
two dataset. Likewise, the correlation between PSK and PTK dataset is 0.86 which actually 
suggested a very good assembling between these two groups. Finally it can be mentioned that, all 
those figures as well as correlation values suggested that mutation pattern of twenty amino acid 
have more or less the similar outline.   
 
6.2.7 Mutability of different amino acid groups for PSK, PTK and background dataset 
During this thesis work, it was also carefully observed the mutability group wise amino acid in 
comparison with background data set with both PSK and PTK group. To find out the pattern of 
amino acid mutability among five different amino acid groups, Figure-5.12 describes outlines of 
amino acid mutability in different groups. Some group has displayed higher mutation occurrence, 
whereas some are less abundant to be mutated compared to their magnitudes in protein sequences. 
For example, in contrast with polar acidic and polar basic group, positively charged basic amino 
acids have expressed higher variability than their sequence proportions, but polar acidic group has 
shown opposite characteristics in this point of view. However, pathogenicity property upon 
variation can be compared nicely among the groups from Figure-5.12. Non polar aliphatic group 
was found most susceptible for causing mutations. Amino acids belong to this group are changing 
more frequently into pathogenic type. 
Yet again Figure-5.12 nicely shows more variability of polar basic amino acids than that of 
aromatic group. Uncharged (neutral) and polar basic amino acid groups have discovered almost 
equivalent mutability. Aromatic amino acid group and polar acidic group show least mutation rate. 
Nevertheless, the non-polar aliphatic group has highest frequency for overall other groups. This 
group has been found maximum probability to be mutated easily and therefore disease causing 
mutations are happening here. In this point of view, polar acidic and aromatic amino acid group was 
found less pathogenic than others. Pathogenicity of non-polar aliphatic group was found almost two 
times higher than polar acidic and aromatic group.  
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6.3 Future perspectives 
This thesis work was intended to found new mutations in Kinase domain as well as found new 
genes where mutations are happening in Kinase domain range and hence established the mutation 
pattern. Within the protein kinase family Serine/Threonine kinases have received comparatively 
lesser attention, in comparison with Tyrosine kinases (Capra et al., 2006). This thesis work also 
highlights the idea that the increasing amount of mutations in PSK which focus PSK should have 
more attention for further research. From this study it can also be proposed that several genes like as 
ACVRL1, STK11, and BTK could be easily mutated in any amino acid positions between their 
kinase ranges. Yet again, in kinase range some amino acid like arginine (R) can be easily and 
frequently mutated. As this study has given wonderful results, it will help in further bioinformatics 
research for disease causing mutations happening in Kinase domain. It will definitely inspire larger 
scale research with other disease causing mutations to find more genes and more frequent positions 
where mutations are happening would be known for each protein coding site of human genome. 
As all these mutations in kinase domain are related with life threatening diseases like cancer, the 
updated version of KinMutBase database will also help the cancer researchers for analysis. 
Sometimes KinMutBase is updated manually. Consequently, it could be a worthy possibility to 
build a system where KinMutBase would be able to accept and conserve the data automatically.  
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7. SUMMARY 
Disease causing mutations are quite related with Kinase domain and causing life threatening 
diseases. Higher mutation rate as well as mutations within kinase domain range for new recorded 
genes in KinMutBase also established the circumstance that kinase domain is susceptible for 
mutations.  
The overall objective of this study was to analyze missense mutation pattern for both PSK and PTK 
groups. Previously Serine kinase receives moderately lesser attention than Tyrosine kinase. But 
recently comprised higher mutation rate in Serine kinase indicates that mutations in PSK kinases 
have similar tendency to be happening like as Tyrosine kinase. Moreover, several genes like as 
ACVRL1, STK11, and BTK could be easily mutated in any amino acid positions between their 
kinase ranges. Therefore more specific study should be required to distinguish beside these genes 
which particular genes are also frequently vulnerable for diseases causing mutations. In addition, 
amino acid mutability studies exposed some motivating aspects for individual specific amino acids 
and different groups of amino acids. Arginine (R) has been found most abundant to be mutated and 
causes diseases, whereas M and N was opposite for both PSK and PTK group. In addition, L and G 
have been found to follow the trend like R for both of that group. However, F, S, T and V were least 
in this consideration.  
Again certain positions in MSA files like 343, 353 for PSK and 158, 163, 185, 186, 189, and 198 
are also have shown the chance to be mutated easily and quiet frequently. More study should be 
done about this fact why these positions are vulnerable for mutations and so on. Over again Non 
Polar aliphatic amino acids groups have been considered as most frequently to be mutated for both 
PSK and PTK group and this have shown two times more pathogenicity than polar acidic amino 
acids and aromatic groups. Polar basic amino acids and Polar uncharged have been found medium 
mutation pattern. 
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